Is Policresulen registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 1 valid registration of Policresulen, including ALBOTHYL VAGINAL OVULE 90MG (90 mg, Suppository, SAR 14.25).

Active substance

Policresulen

SFDA 2

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
ALBOTHYL VAGINAL OVULE 90MG	90 mg	Suppository · Vaginal use	6 Blister	SAR 14.25	NCE · Prescription	ACINO PHARMA AG	Valid
ALBOTHYL CONC.SOLUTION 36%	36 %	Cutaneous solution · Topical	1 Bottle	SAR 20.30	NCE · Prescription	TAKEDA GMBH	Withdrawn by MAH · Not Marketed

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.